Ignite Creation Date:
2024-05-05 @ 11:53 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00167245
Status:
COMPLETED
Last Update Posted:
2020-07-07
First Post:
2005-09-09
Brief Title:
Topiramate for Alcohol and Cocaine Dependence
Sponsor:
Kyle Kampman
Organization:
University of Pennsylvania
Study Overview
Official Title:
A Phase II Randomized Double-blind Placebo-Controlled Pilot Trial of Topiramate for Alcohol and Comorbid Cocaine Dependence
Status:
COMPLETED
Status Verified Date:
2019-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
TOP2
Brief Summary:
The primary purpose of this study is to test the effectiveness of topiramate for the treatment of combined alcohol and cocaine dependence Topiramate is approved for the treatment of seizures It has not been proven to be effective for the treatment of alcohol or cocaine dependence
Detailed Description:
The purpose of this study is to evaluate the efficacy of 300 mgday of topiramate for the treatment of 200 treatment-seeking alcohol dependent outpatients with comorbid cocaine dependence in a double-blind placebo-controlled 14-week trial with a 6-month follow-up 3 months after completing medications
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| R01AA014657 | NIH | None | httpsreporternihgovquickSearchR01AA014657 |